Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T‐cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant
暂无分享,去创建一个
B. Gloss | C. Bateman | S. Avdic | E. Blyth | D. Gottlieb | K. Micklethwaite | J. Street | L. Clancy | D. Bishop | R. Simms | G. Sutrave | Wei Jiang | V. Antonenas | Selmir Avdic